Cargando…
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
Autores principales: | Bueno, Clara, Velasco-Hernandez, Talia, Gutiérrez-Agüera, Francisco, Zanetti, Samanta Romina, Baroni, Matteo L., Sánchez-Martínez, Diego, Molina, Oscar, Closa, Adria, Agraz-Doblás, Antonio, Marín, Pedro, Eyras, Eduardo, Varela, Ignacio, Menéndez, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756031/ https://www.ncbi.nlm.nih.gov/pubmed/30778134 http://dx.doi.org/10.1038/s41375-019-0418-8 |
Ejemplares similares
-
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions
por: Bueno, Clara, et al.
Publicado: (2019) -
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
por: Velasco-Hernandez, Talia, et al.
Publicado: (2020) -
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL
por: Zanetti, Samanta Romina, et al.
Publicado: (2022) -
The “Never-Ending” Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us
por: Ottersbach, Katrin, et al.
Publicado: (2018) -
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
por: Muñoz-López, Alvaro, et al.
Publicado: (2016)